← Back to Search

Anemia testing

Pre-Op Anemia Management for Hip Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age
Undergoing primary arthroplasty procedure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two years
Awards & highlights

Study Summary

This trial will test if pre-op anemia tests and treatment can reduce complications and improve outcomes for hip and knee surgery patients.

Who is the study for?
This trial is for adults over 18 who are scheduled for primary arthroplasty surgery (hip or knee replacement) and can give informed consent. It's not open to patients with end-stage renal disease, those under a nephrologist's care, receiving erythropoietin treatment, or with hematological conditions already being treated for anemia.Check my eligibility
What is being tested?
The study tests if early detection and treatment of anemia before hip or knee replacement surgery improves outcomes. Participants will either follow standard care with anemia testing 2-4 weeks before surgery or be tested at the time they agree to surgery (4-6 months prior), with immediate treatment if needed.See study design
What are the potential side effects?
Since this trial involves testing and potential treatments for pre-operative anemia, side effects may include discomfort from blood draws and reactions to any treatments given to correct anemia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am scheduled for my first joint replacement surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two years
This trial's timeline: 3 weeks for screening, Varies for treatment, and two years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Commencement of treatment by family doctor or self-medication by patients in control arm
Compliance with treatment in the experimental arm
Feasibility - Enrollment
+1 more
Secondary outcome measures
Anemia prevelence
Change in hemoglobin
Hemoglobin levels

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental - anemia testingExperimental Treatment1 Intervention
All patients in the experimental group will undergo a point of care test. Patients who meet the higher point-of-care-testing thresholds as possibly having anemia (female: 130g/L; male: 140g/L) will have a formal complete blood count (CBC) test. Formal CBC will not be ordered for all patients in the experimental group to limit the burden on hospital resources. The study co-ordinator will review CBC levels and contact patients to inform them of their results. Patients identified as having anemia in the formal CBC test will be invited to be reviewed in the PBOC. Patients in the experimental group who do not meet the threshold for possible anemia on the point-of-care test will continue the current pathway and be reassessed in the preoperative assessment clinic at the time of scheduled surgery. Patients in the experimental group who are determined not to have anemia after formal CBC tests will follow the same pathway.
Group II: ControlActive Control1 Intervention
Patients in the control group will not be tested at point of care and will continue on the current pathway and be assessed in the preoperative assessment clinic at the time of scheduled surgery.

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
559 Previous Clinical Trials
2,784,752 Total Patients Enrolled
Canadian Blood ServicesOTHER
20 Previous Clinical Trials
19,839 Total Patients Enrolled

Media Library

DiagnosticTest (Anemia testing) Clinical Trial Eligibility Overview. Trial Name: NCT05648942 — N/A
Hip Osteoarthritis Research Study Groups: Experimental - anemia testing, Control
Hip Osteoarthritis Clinical Trial 2023: DiagnosticTest Highlights & Side Effects. Trial Name: NCT05648942 — N/A
DiagnosticTest (Anemia testing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05648942 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to enroll in this medical experiment at present?

"According to the data published on clinicialtrials.gov, this study is not presently seeking participants. The investigation was posted on January 1st 2023 and edited December 5th 2022; however, there are currently 322 other trials actively recruiting patients."

Answered by AI
~300 spots leftby Jan 2025